GlassScriptPhysician profile
Katayun Saadai
NPI 1225358989
$1,684.37
in general payments reported to CMS, 2019-2025
27 companies · $1,093 in 2025
The $1,093 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.09 · 2020: $11.80 · 2021: $105 · 2022: $27.15 · 2023: $234 · 2024: $161 · 2025: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,488.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $273.78 | 2019-2025 | Winrevair, Gardasil 9, Vaxneuvance |
| Glaxosmithkline, LLC. | $230.87 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $193.07 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.33 | 2025 | Jardiance, Ofev, Jascayd |
| Amgen INC. | $160.91 | 2025 | Evenity, Tavneos |
| Lilly USA, LLC | $68.63 | 2024-2025 | Jardiance, Kisunla, Mounjaro |
| Novo Nordisk INC | $65.97 | 2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $52.77 | 2025 | |
| Aimmune Therapeutics, INC. | $39.23 | 2025 | Zenpep, Vowst |
| Exact Sciences Corporation | $38.61 | 2023 | Cologuard Collection Kit |
| Insmed, INC. | $34.67 | 2025 | Arikayce |
| Teleflex LLC | $30.62 | 2025 | Urolift |
| Astellas Pharma US INC | $27.82 | 2025 | Veozah |
| Ani Pharmaceuticals, INC. | $27.80 | 2025 | Purified Cortrophin Gel |
| Phathom Pharmaceuticals, INC. | $27.55 | 2025 | Voquezna |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $27.07 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Corcept Therapeutics | $26.47 | 2025 | Korlym |
| Qiagen, LLC | $22.08 | 2021 | |
| Boston Scientific Corporation | $20.98 | 2019 | |
| Abbott Laboratories | $19.62 | 2025 | Freestyle Libre 3 |
| United Therapeutics Corporation | $17.47 | 2025 | Tyvaso |
| Silk Road Medical, INC. | $16.98 | 2021 | |
| Zoll Respicardia, INC. | $16.96 | 2025 | Remede System |
| Edwards Lifesciences Corporation | $16.38 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Seqirus USA INC | $14.73 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Nevro Corp. | $14.51 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.49 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katayun Saadai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.